GLP-1 Drugs Lead Peptide-Based Approaches to Addiction Treatment
A review identifies GLP-1 drugs as the leading peptide-based candidates for alcohol use disorder, but major evidence gaps remain.
646 articles
A review identifies GLP-1 drugs as the leading peptide-based candidates for alcohol use disorder, but major evidence gaps remain.
Smoke, heat, and disrupted sleep may threaten firefighters' brain health, but evidence linking these exposures to neurodegeneration remains uncertain.
A review connects disrupted brain signaling with depression and explores treatments targeting receptors, supporting cells, and brain circuits.
A review finds NAD+ precursors have not improved muscle mass or strength in older adults, while exercise combinations remain unproven.
A review links the thioredoxin system to cellular aging and inflammation, but evidence for treatments in aged mammals remains limited.
A new review argues that damaged mitochondria are a shared hub driving neuron loss across five major brain diseases, and it maps the emerging fixes.
Combining GLP-1 and SGLT2 drugs was linked to lower mortality and fewer heart failure hospitalizations after pacemaker implantation in diabetes.
A review explores how declining clearance of toxic fat breakdown products may contribute to Parkinson's—and why antioxidants alone may fall short.
A review of 12 trials found no clear movement benefit from dopamine drugs after stroke. The strongest trials showed essentially no improvement.
Orion offers subscription-free temperature control, but evidence that cooling beds improve sleep or long-term health remains limited.
A review of 97,850 cancer patients links antibiotic exposure to worse immunotherapy outcomes, highlighting careful prescribing—not blanket avoidance.
A systematic review of 10 RCTs (1,098 adults) compares low-carb, low-GI, Mediterranean and fasting diets for prediabetes. Each helps, but none is best for everyone.